How many studies have been conducted on Technetium Tc 99m Pyrophosphate?

BiohacksAI has indexed 26 PubMed studies on Technetium Tc 99m Pyrophosphate, including 1 randomized controlled trials (RCTs). 62% of studies involve human subjects.

What are the main research areas for Technetium Tc 99m Pyrophosphate?

The primary research domains for Technetium Tc 99m Pyrophosphate are ⏳ Longevity & Aging, ❤️ Cardiovascular, 🧠 Neuroprotection. This is based on analysis of 26 PubMed studies using the BiohacksAI evidence platform.

Technetium Tc 99m Pyrophosphate

A radionuclide imaging agent used primarily in scintigraphy or tomography of the heart to evaluate the extent of the necrotic myocardial process. It has also been used in noninvasive tests for the distribution of organ involvement in different types of amyloidosis and for the evaluation of muscle necrosis in the extremities.

26+ PubMed studies analyzed · 1 RCTs · Evidence Score: 49.6

Research Domains

Technetium Tc 99m Pyrophosphate has been studied across 11 research domains including ⏳ Longevity & Aging, ❤️ Cardiovascular, 🧠 Neuroprotection, 🦴 Bone & Joint, ✨ Skin & Hair. The primary research focus is ⏳ Longevity & Aging with 62% of studies addressing this area.

Loading evidence profile...

This evidence profile for Technetium Tc 99m Pyrophosphate is generated deterministically from 26 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.